Two Sigma Investments’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,300
| Closed | -$581K | – | 3005 |
|
|
2024
Q1 | $581K | Sell |
6,300
-13,840
| -69% | -$1.3M | ﹤0.01% | 2262 |
|
|
2023
Q4 | $1.91M | Sell |
20,140
-252
| -1% | -$23.5K | ﹤0.01% | 1598 |
|
|
2023
Q3 | $1.9M | Sell |
20,392
-24,140
| -54% | -$2.23M | 0.01% | 1429 |
|
|
2023
Q2 | $4.07M | Sell |
44,532
-42,521
| -49% | -$3.49M | 0.01% | 1022 |
|
|
2023
Q1 | $6.4M | Buy |
87,053
+22,473
| +35% | +$1.94M | 0.02% | 793 |
|
|
2022
Q4 | $5.4M | Buy |
64,580
+53,603
| +488% | +$4.83M | 0.02% | 818 |
|
|
2022
Q3 | $1.06M | Sell |
10,977
-1,486
| -12% | -$177K | ﹤0.01% | 1438 |
|
|
2022
Q2 | $1.31M | Buy |
+12,463
| New | +$1.59M | ﹤0.01% | 1413 |
|
|
2021
Q4 | – | Sell |
-57,142
| Closed | -$9.18M | – | 4233 |
|
|
2021
Q3 | $8.52M | Buy |
57,142
+22,682
| +66% | +$4.72M | 0.02% | 842 |
|
|
2021
Q2 | $8.44M | Buy |
34,460
+33,488
| +3,445% | +$8.79M | 0.02% | 900 |
|
|
2021
Q1 | $257K | Sell |
972
-14,095
| -94% | -$3.98M | ﹤0.01% | 3452 |
|
|
2020
Q4 | $4.42M | Sell |
15,067
-91,208
| -86% | -$23.4M | 0.01% | 1009 |
|
|
2020
Q3 | $25.1M | Buy |
106,275
+73,683
| +226% | +$16.8M | 0.09% | 243 |
|
|
2020
Q2 | $6.47M | Sell |
32,592
-1,443
| -4% | -$269K | 0.03% | 543 |
|
|
2020
Q1 | $6.25M | Buy |
+34,035
| New | +$6.06M | 0.05% | 412 |
|
|
2019
Q2 | – | Sell |
-67,212
| Closed | -$7.98M | – | 3290 |
|
|
2019
Q1 | $8.29M | Buy |
67,212
+5,576
| +9% | +$700K | 0.03% | 731 |
|
|
2018
Q4 | $7.22M | Sell |
61,636
-3,204
| -5% | -$378K | 0.03% | 644 |
|
|
2018
Q3 | $8.1M | Buy |
64,840
+59,013
| +1,013% | +$6.52M | 0.02% | 733 |
|
|
2018
Q2 | $498K | Sell |
5,827
-32,339
| -85% | -$2.37M | ﹤0.01% | 2648 |
|
|
2018
Q1 | $2.3M | Sell |
38,166
-121,524
| -76% | -$6.92M | 0.01% | 1429 |
|
|
2017
Q4 | $8.42M | Buy |
+159,690
| New | +$8.42M | 0.03% | 674 |
|
|
2017
Q3 | – | Sell |
-32,838
| Closed | -$2.06M | – | 2710 |
|
|
2017
Q2 | $2.06M | Buy |
+32,838
| New | +$1.91M | 0.01% | 1400 |
|
|
2016
Q2 | – | Sell |
-70,279
| Closed | -$3.4M | – | 2880 |
|
|
2016
Q1 | $3.4M | Buy |
70,279
+19,509
| +38% | +$753K | 0.02% | 888 |
|
|
2015
Q4 | $2M | Buy |
+50,770
| New | +$2.03M | 0.01% | 1098 |
|
|
2015
Q3 | – | Sell |
-62,564
| Closed | -$2.49M | – | 2163 |
|
|
2015
Q2 | $2.49M | Buy |
62,564
+52,526
| +523% | +$1.64M | 0.01% | 1071 |
|
|
2015
Q1 | $269K | Sell |
10,038
-85,345
| -89% | -$2.41M | ﹤0.01% | 2331 |
|
|
2014
Q4 | $2.8M | Sell |
95,383
-51,345
| -35% | -$1.27M | 0.02% | 880 |
|
|
2014
Q3 | $2.96M | Buy |
146,728
+29,569
| +25% | +$570K | 0.01% | 759 |
|
|
2014
Q2 | $1.96M | Buy |
117,159
+104,536
| +828% | +$1.48M | 0.01% | 1030 |
|
|
2014
Q1 | $188K | Sell |
12,623
-82,122
| -87% | -$1.26M | ﹤0.01% | 1824 |
|
|
2013
Q4 | $1.39M | Buy |
94,745
+30,789
| +48% | +$496K | 0.01% | 1173 |
|
|
2013
Q3 | $1.1M | Buy |
63,956
+8,476
| +15% | +$126K | 0.01% | 990 |
|
|
2013
Q2 | $645K | Buy |
+55,480
| New | +$636K | ﹤0.01% | 1287 |
|
Other funds holding AMED
FCM
AAM
WCMNY
PCM
Two Sigma Investments's AMED Position: Q2 2024 in Review
Two Sigma Investments sold out of Amedisys (AMED) in Q2 2024, closing a stake of 6,300 shares — an estimated $581K sold.
Two Sigma Investments first reported a position in AMED in Q2 2013 and held it in 33 quarters. The position peaked at $25.1M in Q3 2020. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2024.
- Two Sigma Investments reported no remaining Amedisys position as of Q2 2024 after selling out during the quarter.
- Two Sigma Investments sold 6,300 Amedisys shares in Q2 2024, an estimated $581K.
- Two Sigma Investments first reported a position in Amedisys in Q2 2013 and held it in 33 quarters.
- Two Sigma Investments's Amedisys position peaked at $25.1M in Q3 2020.
- 288 funds tracked by Wall St. Rank held Amedisys as of Q2 2024.
Based on Two Sigma Investments's 13F filing for Q2 2024, filed 14 Aug 2024.